Loading insider details...
Latest Form 4 (Jun 30, 2026): Grant/Award of 155,000 IKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 155,000 | n/a |
| Feb 25, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to Issuer | 255,299 | n/a |
| Jul 2, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 108,176 | n/a |
| Feb 25, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 134,427 | n/a |
| May 24, 2024 | Longboard Pharmaceuticals, Inc. (LBPH) | Grant/Award | 22,500 | n/a |